3,8 Additional effects of GLP-1 include slowing gastric emptying, reducing appetite, and aiding in weight loss
C., Perez, E., Rapuano, A., Sandhu, M
Rather than cannibalizing significant market share from injectables, oral formulations are more likely to expand the total patient population eligible for these therapies
Event: First Status Conference Date Set Date: February 16, 2024 Notes: Judge Pratter announces that the first status conference of the Ozempic lawsuit will be on March 14, 2024
Insurance coverage represents another major barrier to broader adoption
Mar 2, 2026 A capsule that claims to boost your GLP-1 levels by 300%